Effects of Citrullus colocynthis L. in a rat model of diabetic neuropathy

M Ostovar, A Akbari, MH Anbardar, A Iraji… - Journal of Integrative …, 2020 - Elsevier
Objective This study investigated the biochemical, histopathological and physiological
effects of Citrullus colocynthis on peripheral neuropathy in rats with streptozotocin (STZ) …

[HTML][HTML] Shedding light on the pharmacological interactions between μ-opioid analgesics and angiotensin receptor modulators: A new option for treating chronic pain

K Király, DÁ Karádi, F Zádor, A Mohammadzadeh… - Molecules, 2021 - mdpi.com
The current protocols for neuropathic pain management include µ-opioid receptor (MOR)
analgesics alongside other drugs; however, there is debate on the effectiveness of opioids …

[HTML][HTML] Triphala churna—a traditional formulation in ayurveda mitigates diabetic neuropathy in rats

SV Suryavanshi, K Barve, V Addepalli… - Frontiers in …, 2021 - frontiersin.org
Neuropathy is a common complication of diabetes affecting a large number of people
worldwide. Triphala churna is a formulation mentioned in Ayurveda-a traditional system of …

Extracellular matrix remodeling and modulation of inflammation and oxidative stress by sulforaphane in experimental diabetic peripheral neuropathy

PE Moustafa, NF Abdelkader, SA El Awdan… - Inflammation, 2018 - Springer
The peripheral nervous system is one of many organ systems that can be profoundly
impacted in diabetes mellitus. Diabetic peripheral neuropathy has a significant negative …

Neuroprotective effect of paeonol in streptozotocin-induced diabetes in rats

KM Adki, YA Kulkarni - Life Sciences, 2021 - Elsevier
Background Diabetic neuropathy is one of the most common microvascular complication of
diabetes. It is associated with neuronal dysfunction and pain. Paeonol is an important …

[HTML][HTML] In silico drug repurposing framework predicts repaglinide, agomelatine and protokylol as TRPV1 modulators with analgesic activity

C Andrei, DP Mihai, A Zanfirescu, GM Nitulescu… - Pharmaceutics, 2022 - mdpi.com
Pain is one of the most common symptoms experienced by patients. The use of current
analgesics is limited by low efficacy and important side effects. Transient receptor potential …

[HTML][HTML] Telmisartan is a promising agent for managing neuropathic pain and delaying opioid analgesic tolerance in rats

DÁ Karádi, AR Galambos, PP Lakatos… - International Journal of …, 2023 - mdpi.com
Despite the large arsenal of analgesic medications, neuropathic pain (NP) management is
not solved yet. Angiotensin II receptor type 1 (AT1) has been identified as a potential target …

Demystifying the dual role of the angiotensin system in neuropathic pain

S Kaur, A Bali, N Singh, AS Jaggi - Neuropeptides, 2022 - Elsevier
Neuropathic Pain is caused by damage to a nerve or disease of the somatosensory nervous
system. Apart from the blood pressure regulating actions of angiotensin ligands, studies …

[HTML][HTML] The somatostatin receptor-4 agonist J-2156 alleviates mechanical hypersensitivity in a rat model of breast cancer induced bone pain

PA Shenoy, A Kuo, N Khan, L Gorham… - Frontiers in …, 2018 - frontiersin.org
In the majority of patients with breast cancer in the advanced stages, skeletal metastases are
common, which may cause excruciating pain. Currently available drug treatments for relief of …

Escin alleviates peripheral neuropathy in streptozotocin induced diabetes in rats

SV Suryavanshi, YA Kulkarni - Life sciences, 2020 - Elsevier
Aim Inflammatory cascade and oxidative stress play a central role in diabetic peripheral
neuropathy via activation of inflammatory cytokines. Escin has potent antioxidant and anti …